Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

32.1K
Overview
32.1K
Inflammation01:38

Inflammation

61.8K
Overview
61.8K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.4K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.4K
SN1 Reaction: Stereochemistry02:15

SN1 Reaction: Stereochemistry

10.2K
This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.2K
SN1 Reaction: Kinetics02:05

SN1 Reaction: Kinetics

9.5K
In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
9.5K
SN1 Reaction: Mechanism02:25

SN1 Reaction: Mechanism

14.1K
Kinetic studies of ionization of a tertiary halide in a protic solvent suggest that only the substrate participates in the rate-determining step (slow step). The nucleophile is involved only after the slowest step. The SN1 reaction takes place in a multiple-step mechanism. 
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconsidering biologic treatment recommendations for CRSwNP without asthma in EUFOREA guidelines.

Rhinology·2026
Same author

Efficacy of 5-Grass Pollen Liquid Sublingual Allergen Immunotherapy for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.

Journal of investigational allergology & clinical immunology·2025
Same author

Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

Triple inhaled therapy in asthma: Beliefs, behaviours and doubts.

Pulmonary pharmacology & therapeutics·2024
Same author

Biologics and airway remodeling in asthma: early, late, and potential preventive effects.

Allergy·2024

Related Experiment Video

Updated: Jan 23, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.8K

[ICAM-1 and allergic inflammation]

G W Canonica1

  • 1Département de Médecine Interne, Université de Gênes, Italie.

Allergie Et Immunologie
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Asthma treatment is shifting towards long-term illness control, not just symptom relief. Intercellular Adhesion Molecule-1 (ICAM-1) is a key target for preventing viral asthma, suggesting new therapeutic strategies beyond antihistamines.

More Related Videos

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

6.5K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.1K

Related Experiment Videos

Last Updated: Jan 23, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.8K
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

6.5K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.1K

Area of Science:

  • Immunology
  • Pulmonology
  • Pharmacology

Context:

  • Advances in understanding asthma pathophysiology.
  • Need for evolving treatment objectives from symptomatic to disease control.
  • Viral infections as a significant trigger for asthma.

Purpose:

  • To explore the potential of Intercellular Adhesion Molecule-1 (ICAM-1) as a therapeutic target.
  • To evaluate novel treatment strategies for viral-induced asthma.
  • To reassess the role of traditional antihistamines in asthma management.

Summary:

  • Intercellular Adhesion Molecule-1 (ICAM-1) presents a promising target for the preventative treatment of viral asthma.
  • Combined therapies involving histamine inhibition and ICAM-1 regulation offer a superior alternative to simple antihistamines.
  • This approach facilitates a transition towards prolonged asthma control, addressing the underlying disease mechanisms.

Impact:

  • Potential for developing new preventative therapies for viral asthma.
  • Shift in asthma management paradigms towards disease modification.
  • Improved long-term outcomes for asthma patients, particularly those with viral triggers.